Medtronic/Renesas
This article was originally published in The Gray Sheet
Executive Summary
Technology alliance will manufacture and supply two-chip system for digital processing and display functions in glucose meters. Combining Medtronic analog/mixed signal Analog Front End Application-Specific Standard Product technology and Renesas' H8 low power microcontrollers, the chip sets will be showcased at the Embedded Systems Conference April 23-25 in San Francisco. Renesas is a joint venture of Hitatchi and Mitsubishi Electric...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.